Cargando…

Identification of the Mycobacterium ulcerans Protein MUL_3720 as a Promising Target for the Development of a Diagnostic Test for Buruli Ulcer

Buruli ulcer (BU) caused by Mycobacterium ulcerans is a devastating skin disease, occurring mainly in remote West African communities with poor access to health care. Early case detection and subsequent antibiotic treatment are essential to counteract the progression of the characteristic chronic ul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dreyer, Anita, Röltgen, Katharina, Dangy, Jean Pierre, Ruf, Marie Thérèse, Scherr, Nicole, Bolz, Miriam, Tobias, Nicholas Jay, Moes, Charles, Vettiger, Andrea, Stinear, Timothy Paul, Pluschke, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344477/ https://www.ncbi.nlm.nih.gov/pubmed/25668636 http://dx.doi.org/10.1371/journal.pntd.0003477

Ejemplares similares

Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer
por: Bolz, Miriam, et al.
Publicado: (2016)

The cell surface protein MUL_3720 confers binding of the skin pathogen Mycobacterium ulcerans to sulfated glycans and keratin
por: Day, Christopher J., et al.
Publicado: (2021)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2020)

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model
por: Bolz, Miriam, et al.
Publicado: (2016)

Experimental Infection of the Pig with Mycobacterium ulcerans: A Novel Model for Studying the Pathogenesis of Buruli Ulcer Disease
por: Bolz, Miriam, et al.
Publicado: (2014)

High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice
por: Mangas, Kirstie M., et al.
Publicado: (2020)

Single Nucleotide Polymorphism Typing of Mycobacterium ulcerans Reveals Focal Transmission of Buruli Ulcer in a Highly Endemic Region of Ghana
por: Röltgen, Katharina, et al.
Publicado: (2010)

Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer–Endemic Area, Northern Queensland, Australia
por: Röltgen, Katharina, et al.
Publicado: (2017)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis
por: Ruf, Marie-Thérèse, et al.
Publicado: (2016)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

Targeting the Mycobacterium ulcerans cytochrome bc(1):aa(3) for the treatment of Buruli ulcer
por: Scherr, Nicole, et al.
Publicado: (2018)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms
por: Bibert, Stéphanie, et al.
Publicado: (2017)

Structure-Activity Relationship Studies on the Macrolide Exotoxin Mycolactone of Mycobacterium ulcerans
por: Scherr, Nicole, et al.
Publicado: (2013)

Locally Confined Clonal Complexes of Mycobacterium ulcerans in Two Buruli Ulcer Endemic Regions of Cameroon
por: Bolz, Miriam, et al.
Publicado: (2015)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2020)

Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice
por: Bieri, Raphael, et al.
Publicado: (2016)

Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital
por: Please, Helen R., et al.
Publicado: (2021)

Understanding the transmission of Mycobacterium ulcerans: A step towards controlling Buruli ulcer
por: Muleta, Anthony J., et al.
Publicado: (2021)

Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control
por: Johnson, Paul D. R, et al.
Publicado: (2005)

Correction: Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control
por: Johnson, Paul D. R, et al.
Publicado: (2005)

Mycobacterium ulcerans in Mosquitoes Captured during Outbreak of Buruli Ulcer, Southeastern Australia
por: Johnson, Paul D.R., et al.
Publicado: (2007)

Genomic Diversity and Evolution of Mycobacterium ulcerans Revealed by Next-Generation Sequencing
por: Qi, Weihong, et al.
Publicado: (2009)

The Incubation Period of Buruli Ulcer (Mycobacterium ulcerans Infection)
por: Trubiano, Jason A., et al.
Publicado: (2013)

Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
por: Yotsu, Rie R, et al.
Publicado: (2018)

Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria
por: Ruf, Marie-Thérèse, et al.
Publicado: (2017)

Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans
por: Dangy, Jean-Pierre, et al.
Publicado: (2016)

Mycobacterium ulcerans Population Genomics To Inform on the Spread of Buruli Ulcer across Central Africa
por: Vandelannoote, Koen, et al.
Publicado: (2019)

Mycobacterium ulcerans not detected by PCR on human skin in Buruli ulcer endemic areas of south eastern Australia
por: Velink, Anita, et al.
Publicado: (2023)

Ongoing Genome Reduction in Mycobacterium ulcerans
por: Rondini, Simona, et al.
Publicado: (2007)

Spontaneous Clearance of Mycobacterium ulcerans in a Case of Buruli Ulcer
por: Gordon, Claire L., et al.
Publicado: (2011)

Development of a Temperature-Switch PCR-Based SNP Typing Method for Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2012)

Introduction of Mycobacterium ulcerans disease in the Bankim Health District of Cameroon follows damming of the Mapé River
por: Vandelannoote, Koen, et al.
Publicado: (2020)

Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease
por: Bolz, Miriam, et al.
Publicado: (2015)

Aquatic Insects and Mycobacterium ulcerans: An Association Relevant to Buruli Ulcer Control?
por: Silva, Manuel T, et al.
Publicado: (2007)

Risk of Buruli Ulcer and Detection of Mycobacterium ulcerans in Mosquitoes in Southeastern Australia
por: Lavender, Caroline J., et al.
Publicado: (2011)

Detection of Mycobacterium ulcerans in the Environment Predicts Prevalence of Buruli Ulcer in Benin
por: Williamson, Heather R., et al.
Publicado: (2012)

Linking the Mycobacterium ulcerans environment to Buruli ulcer disease: Progress and challenges
por: Dhungel, Laxmi, et al.
Publicado: (2021)

Improved Protective Efficacy of a Species-Specific DNA Vaccine Encoding Mycolyl-Transferase Ag85A from Mycobacterium ulcerans by Homologous Protein Boosting
por: Tanghe, Audrey, et al.
Publicado: (2008)

Mycobacterium ulcerans DNA Not Detected in Faecal Samples from Buruli Ulcer Patients: Results of a Pilot Study
por: Sarfo, Fred S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8o23tbds3tobb8ct539jrk7s6f